Search

Your search keyword '"Mazzarella L"' showing total 762 results

Search Constraints

Start Over You searched for: Author "Mazzarella L" Remove constraint Author: "Mazzarella L"
762 results on '"Mazzarella L"'

Search Results

2. Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion

5. Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial

8. P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology

9. 71P Molecular Tumor Board at the European Institute of Oncology: An early Italian precision oncology experience

10. Impact of the Current on Reverse Bias Degradation of Perovskite Solar Cells

11. Vacuum Deposited Perovskites with a Controllable Crystal Orientation

12. Crystallization Process for High-Quality Cs0.15FA0.85PbI2.85Br0.15Film Deposited via Simplified Sequential Vacuum Evaporation

13. Optical Simulation-Aided Design and Engineering of Monolithic Perovskite/Silicon Tandem Solar Cells

14. Strategies for realizing high-efficiency silicon heterojunction solar cells

15. Poly-SiOx Passivating Contacts with Plasma-Assisted N2O Oxidation of Silicon (PANO-SiOx)

16. Crystalline silicon solar cells with thin poly-SiOx carrier-selective passivating contacts for perovskite/c-Si tandem applications

18. 83P The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population

20. Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis

21. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications

22. Slow Shallow Energy States as the Origin of Hysteresis in Perovskite Solar Cells

23. Progress and challenges on scaling up of perovskite solar cell technology

24. Controllable Simultaneous Bifacial Cu-Plating for High-Efficiency Crystalline Silicon Solar Cells

25. Tumor infiltrating iNKT cells sustain neutrophil pro-tumorigenic functions influencing disease progression in human colorectal cancer

26. Efficient Continuous Light-Driven Electrochemical Water Splitting Enabled by Monolithic Perovskite-Silicon Tandem Photovoltaics

27. Achieving 23.83% conversion efficiency in silicon heterojunction solar cell with ultra-thin MoOx hole collector layer via tailoring (i)a-Si:H/MoOx interface

28. Effects of (i)a-Si: H deposition temperature on high-efficiency silicon heterojunction solar cells

29. Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs

31. Progress and challenges on scaling up of perovskite solar cell technology

32. 79P Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy

34. 1072P Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

37. Design and optimization of hole collectors based on nc-SiOx:H for high-efficiency silicon heterojunction solar cells

38. Oxygen-alloyed poly-Si passivating contacts for high-thermal budget c-Si heterojunction solar cells

39. Room-temperature sputtered tungsten-doped indium oxide for improved current in silicon heterojunction solar cells

40. A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics

41. Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non–Small-Cell Lung Cancer

43. 2406P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell carcinoma of the penis: Subgroup analysis of the PEVOsq basket trial

44. 758P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic vulvar and vaginal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial

45. 557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial

50. Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism

Catalog

Books, media, physical & digital resources